h laboratory and animal testing. It is believed to act by inhibiting the entry of HIV and other pathogens into body cells. BufferGel, a product of ReProtect, Inc., Baltimore, MD, boosts the natural acidity of the vagina in the presence of seminal fluid that neutralizes the vaginal environment. An acidic environment inactivates HIV as well as other pathogens.
Each woman in the trial will be placed at random into one of four equally sized groups. One group will use BufferGel before each act of sexual intercourse, one group will use PRO 2000, one group will use a placebo gel, and the final group will not use any gel. In addition, all participants will receive condoms and extensive prevention counseling at each clinic visit.
The trial is one of numerous studies conducted through NIH's HIV Prevention Trials Network (HPTN), which is funded by NIAID, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse and the National Institute of Mental Health. More information about this study (HPTN 035) is available at www.hptn.org/index.htm. The protocol chair of the study is Salim Abdool Karim, MBChB, Ph.D., of the University of KwaZulu-Natal in Durban, South Africa.
Page: 1 2 Related medicine news :1
Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases
. International breast cancer prevention study launches in the United States and Canada2
. National Academies advisory: May 2 Symposium on International Science Policy3
. Awards & fellowships at the International & American Association for Dental Research General Session4
. Lectures, keynoters, symposia highlight International Dental Research meeting5
. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress6
. International gathering of experts to share retinoblastoma breakthroughs7
. International gathering at UH examines top computer code8
. International trial finds benefits of breast MRI in women at high risk9
. International study provides culture-by-culture clues to family violence and abuse10
. St. Jude scientist wins International Society of Experimental Hematology award11
. International MRC trial finds a routine treatment for head injury may do more harm than good